Links between metabolism and cancer.

Metabolism generates oxygen radicals, which contribute to oncogenic mutations. Activated oncogenes and loss of tumor suppressors in turn alter metabolism and induce aerobic glycolysis. Aerobic glycolysis or the Warburg effect links the high rate of glucose fermentation to cancer. Together with glutamine, glucose via glycolysis provides the carbon skeletons, NADPH, and ATP to build new cancer cells, which persist in hypoxia that in turn rewires metabolic pathways for cell growth and survival. Excessive caloric intake is associated with an increased risk for cancers, while caloric restriction is protective, perhaps through clearance of mitochondria or mitophagy, thereby reducing oxidative stress. Hence, the links between metabolism and cancer are multifaceted, spanning from the low incidence of cancer in large mammals with low specific metabolic rates to altered cancer cell metabolism resulting from mutated enzymes or cancer genes.

[1]  P. Carmeliet,et al.  Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis (vol 394, pg 485, 1998) , 1998 .

[2]  L. Coussens,et al.  Immune microenvironments in solid tumors: new targets for therapy. , 2011, Genes & development.

[3]  Chi V Dang,et al.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. , 2010, Cancer research.

[4]  Gregory Stephanopoulos,et al.  Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis , 2012, BMC Proceedings.

[5]  Gavin Kelly,et al.  Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. , 2012, Cancer discovery.

[6]  David Botstein,et al.  Metabolic cycling in single yeast cells from unsynchronized steady-state populations limited on glucose or phosphate , 2010, Proceedings of the National Academy of Sciences.

[7]  Yanping Zhang,et al.  The Ribosomal Protein-Mdm2-p53 Pathway and Energy Metabolism: Bridging the Gap between Feast and Famine. , 2011, Genes & cancer.

[8]  J. Licht,et al.  Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. , 2010, Cancer cell.

[9]  Frank M. Sacks,et al.  IDH 1 and IDH 2 Mutations in Gliomas , 2009 .

[10]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1 , 2007, Molecular and Cellular Biology.

[11]  Paolo Sassone-Corsi,et al.  Connecting Threads: Epigenetics and Metabolism , 2012, Cell.

[12]  B. Spiegelman,et al.  Molecular mechanisms of cancer development in obesity , 2011, Nature Reviews Cancer.

[13]  T. Finkel,et al.  Signal transduction by reactive oxygen species , 2011, The Journal of cell biology.

[14]  J. Nevins,et al.  Ras enhances Myc protein stability. , 1999, Molecular cell.

[15]  Kevin M. Ryan,et al.  p53 and metabolism , 2009, Nature Reviews Cancer.

[16]  Jason W. Locasale,et al.  Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses , 2011, Science.

[17]  A. Levine,et al.  Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function , 2010, Proceedings of the National Academy of Sciences.

[18]  G. Semenza,et al.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.

[19]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[20]  D. Dressman,et al.  Heteroplasmic mitochondrial DNA mutations in normal and tumor cells , 2010, Nature.

[21]  Kun-Liang Guan,et al.  Regulation of intermediary metabolism by protein acetylation. , 2011, Trends in biochemical sciences.

[22]  G. Semenza,et al.  Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression , 2010, Proceedings of the National Academy of Sciences.

[23]  S. Kalhan,et al.  The Key Role of Anaplerosis and Cataplerosis for Citric Acid Cycle Function* , 2002, The Journal of Biological Chemistry.

[24]  William A Weiss,et al.  Principles and Current Strategies for Targeting Autophagy for Cancer Treatment , 2011, Clinical Cancer Research.

[25]  D. Kilburn,et al.  The energetics of mammalian cell growth. , 1969, Journal of cell science.

[26]  O. Warburg On the origin of cancer cells. , 1956, Science.

[27]  H. Stanley,et al.  Common scale-invariant patterns of sleep-wake transitions across mammalian species. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Yixue Li,et al.  Regulation of Cellular Metabolism by Protein Lysine Acetylation , 2010, Science.

[30]  R. Wilson,et al.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.

[31]  D. Botstein,et al.  Metabolic cycling without cell division cycling in respiring yeast , 2011, Proceedings of the National Academy of Sciences.

[32]  J. Pouysségur,et al.  Hypoxia and energetic tumour metabolism. , 2011, Current opinion in genetics & development.

[33]  E. Gottlieb,et al.  Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.

[34]  John D Gordan,et al.  HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. , 2007, Cancer cell.

[35]  이연수 Functional genomics reveal that the serine synthesis pathway is essential in breast cancer , 2011 .

[36]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[37]  D. Ayer,et al.  An extended Myc network contributes to glucose homeostasis in cancer and diabetes. , 2011, Frontiers in bioscience.

[38]  C. Thompson,et al.  Akt-dependent transformation: there is more to growth than just surviving , 2005, Oncogene.

[39]  Paolo Sassone-Corsi,et al.  Metabolism and cancer: the circadian clock connection , 2009, Nature Reviews Cancer.

[40]  Christian M. Metallo,et al.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.

[41]  W. Marston Linehan,et al.  Reductive carboxylation supports growth in tumor cells with defective mitochondria , 2011, Nature.

[42]  L. Jacobs,et al.  Fatty acid synthesis: a potential selective target for antineoplastic therapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Jason W Locasale,et al.  Metabolic flux and the regulation of mammalian cell growth. , 2011, Cell metabolism.

[44]  Zhiping Weng,et al.  Global mapping of c-Myc binding sites and target gene networks in human B cells , 2006, Proceedings of the National Academy of Sciences.

[45]  P. Carmeliet,et al.  Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.

[46]  Jesse M. Platt,et al.  Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability , 2011, Proceedings of the National Academy of Sciences.

[47]  David M. Sabatini,et al.  Tumours with PI3K activation are resistant to dietary restriction , 2009, Nature.

[48]  G. Mills,et al.  Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and -independent mechanisms , 2011, Nature Medicine.

[49]  G. Semenza HIF-1: upstream and downstream of cancer metabolism. , 2010, Current opinion in genetics & development.

[50]  K. Bhat,et al.  An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. , 2010, Cancer cell.

[51]  D. Ayer,et al.  Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity , 2009, Proceedings of the National Academy of Sciences.

[52]  S. Hankinson,et al.  Night Work and Risk of Breast Cancer , 2006, Epidemiology.

[53]  J. Nagy,et al.  Why don't all whales have cancer? A novel hypothesis resolving Peto's paradox. , 2007, Integrative and comparative biology.

[54]  Bert Vogelstein,et al.  Somatic mutations of the mitochondrial genome in human colorectal tumours , 1998, Nature Genetics.

[55]  D. Felsher,et al.  MYC as a regulator of ribosome biogenesis and protein synthesis , 2010, Nature Reviews Cancer.

[56]  C. Townsend,et al.  Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. , 2003, Cancer research.

[57]  S. Sugano,et al.  Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species , 2010, Proceedings of the National Academy of Sciences.

[58]  J. Maris,et al.  Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha. , 2010, Cancer research.

[59]  B. Wold,et al.  Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression. , 1994, Molecular biology of the cell.

[60]  James R Broach,et al.  Protein kinase A and TORC1 activate genes for ribosomal biogenesis by inactivating repressors encoded by Dot6 and its homolog Tod6 , 2009, Proceedings of the National Academy of Sciences.

[61]  Noel Southall,et al.  Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase. , 2010, Bioorganic & medicinal chemistry letters.

[62]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[63]  J. Nevins,et al.  A Role for E2F Activities in Determining the Fate of Myc-Induced Lymphomagenesis , 2009, PLoS genetics.

[64]  S. Perkins,et al.  Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. , 2010, Carcinogenesis.

[65]  I. Ben-Sahra,et al.  Metformin and cancer therapy , 2012, Current opinion in oncology.

[66]  D. Tindall,et al.  Dynamic FoxO transcription factors , 2007, Journal of Cell Science.

[67]  Brian Keith,et al.  HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. , 2008, Cancer cell.

[68]  A. Alavi,et al.  Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.

[69]  Steven L McKnight,et al.  Restriction of DNA Replication to the Reductive Phase of the Metabolic Cycle Protects Genome Integrity , 2007, Science.

[70]  Abhishek K. Jha,et al.  Full-length human glutaminase in complex with an allosteric inhibitor. , 2011, Biochemistry.

[71]  J. Uhm An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2009 .

[72]  C. Dang,et al.  Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. , 2010, Cancer cell.

[73]  Peder E. Z. Larson,et al.  13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. , 2011, Cell metabolism.

[74]  Tak W. Mak,et al.  Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations , 2010, The Journal of experimental medicine.

[75]  Chenguang Wang,et al.  Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect , 2011, Cell cycle.

[76]  T. Fan,et al.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. , 2012, Cell metabolism.

[77]  Bin Wang,et al.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. , 2011, Cancer cell.

[78]  Eileen White,et al.  Autophagy and Metabolism , 2010, Science.

[79]  M. V. Vander Heiden Targeting cancer metabolism: a therapeutic window opens. , 2011, Nature reviews. Drug discovery.

[80]  H. Christofk,et al.  Identification of small molecule inhibitors of pyruvate kinase M2. , 2010, Biochemical pharmacology.

[81]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[82]  J. Cleveland,et al.  c-myc transactivates the ornithine decarboxylase gene. , 1992, Current topics in microbiology and immunology.

[83]  N. Isern,et al.  c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry , 2009, Oncogene.

[84]  A. Levine,et al.  The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes , 2010, Science.

[85]  C. Supuran,et al.  Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors. , 2011, Journal of medicinal chemistry.

[86]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[87]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[88]  Rameen Beroukhim,et al.  Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene. , 2011, Cancer discovery.

[89]  M. Dewhirst,et al.  Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. , 2005, Cancer research.

[90]  Ana Maria Cuervo,et al.  Autophagy in the cellular energetic balance. , 2011, Cell metabolism.

[91]  C. Maley,et al.  Peto's Paradox: evolution's prescription for cancer prevention. , 2011, Trends in ecology & evolution.

[92]  Tsung-Cheng Chang,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.

[93]  Joseph S. Takahashi,et al.  Circadian Integration of Metabolism and Energetics , 2010, Science.

[94]  J. Zhuang,et al.  p53: exercise capacity and metabolism , 2012, Current opinion in oncology.

[95]  D. Rubinsztein,et al.  Autophagy and Aging , 2011, Cell.

[96]  Hongkai Ji,et al.  Cell-Type Independent MYC Target Genes Reveal a Primordial Signature Involved in Biomass Accumulation , 2011, PloS one.

[97]  B. Faubert,et al.  Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. , 2011, Genes & development.

[98]  Davide Ruggero,et al.  Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency , 2008, Nature.

[99]  A. Dey,et al.  Using a functional enzyme model to understand the chemistry behind hydrogen sulfide induced hibernation , 2009, Proceedings of the National Academy of Sciences.

[100]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[101]  Brian Keith,et al.  HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression , 2011, Nature Reviews Cancer.

[102]  Succinate dehydrogenase. , 1973, Advances in enzymology and related areas of molecular biology.

[103]  N. Ilić,et al.  PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis , 2011, Proceedings of the National Academy of Sciences.

[104]  L. Lau,et al.  Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[105]  P. Ray,et al.  Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. , 2012, Cellular signalling.

[106]  Sterling C. Johnson,et al.  Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys , 2009, Science.

[107]  Takashi Tsukamoto,et al.  Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. , 2012, Cell metabolism.

[108]  H. Coller,et al.  The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. , 2010, Genes & development.

[109]  R. Deberardinis,et al.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer , 2010, Oncogene.

[110]  Patrick H Bradley,et al.  Yeast cells can access distinct quiescent states. , 2011, Genes & development.

[111]  V. Longo,et al.  Calorie restriction and cancer prevention: metabolic and molecular mechanisms. , 2010, Trends in pharmacological sciences.

[112]  H. Christofk,et al.  Identification of small molecule inhibitors of pyruvate kinase M 2 , 2010 .

[113]  J. Marine,et al.  Suppression of Myc oncogenic activity by nucleostemin haploinsufficiency , 2012, Oncogene.

[114]  James H Brown,et al.  Scaling of number, size, and metabolic rate of cells with body size in mammals , 2007, Proceedings of the National Academy of Sciences.

[115]  A. Yalçin,et al.  Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. , 2009, Experimental and molecular pathology.

[116]  Kathryn A. O’Donnell,et al.  Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis , 2005, Molecular and Cellular Biology.

[117]  Kathryn A. O’Donnell,et al.  The c-Myc target gene network. , 2006, Seminars in cancer biology.

[118]  R. Youle,et al.  Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.

[119]  J. Dark,et al.  Annual lipid cycles in hibernators: integration of physiology and behavior. , 2005, Annual review of nutrition.

[120]  A. Schulze,et al.  Targeting cancer metabolism--aiming at a tumour's sweet-spot. , 2012, Drug discovery today.

[121]  Eyal Gottlieb,et al.  TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.

[122]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[123]  O. Delpuech,et al.  FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression , 2011, Cell Death and Differentiation.

[124]  G. Semenza,et al.  Hypoxia-Inducible Factors in Physiology and Medicine , 2012, Cell.

[125]  P. Robson,et al.  Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis , 2012, Cell.

[126]  M. Oren,et al.  Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis. , 2012, Molecular cell.

[127]  V. Savage,et al.  A Quantitative Theory of Solid Tumor Growth, Metabolic Rate and Vascularization , 2011, PloS one.

[128]  M E Greenberg,et al.  Myc requires distinct E2F activities to induce S phase and apoptosis. , 2001, Molecular cell.

[129]  C. Grandori,et al.  Activation by c-Myc of transcription by RNA polymerases I, II and III. , 2006, Biochemical Society symposium.

[130]  C. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[131]  Gregory Stephanopoulos,et al.  Quantifying Reductive Carboxylation Flux of Glutamine to Lipid in a Brown Adipocyte Cell Line* , 2008, Journal of Biological Chemistry.

[132]  D. Sabatini,et al.  mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.

[133]  K. Kaluarachchi,et al.  Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. , 2010, The Journal of clinical investigation.

[134]  J. Siegel Clues to the functions of mammalian sleep , 2005, Nature.

[135]  A. Cassago,et al.  Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism , 2012, Proceedings of the National Academy of Sciences.

[136]  John A. Hall,et al.  mtDNA mutations increase tumorigenicity in prostate cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[137]  M. Celeste Simon,et al.  The impact of O2 availability on human cancer , 2008, Nature Reviews Cancer.

[138]  R. Klose,et al.  The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases , 2011, EMBO reports.

[139]  Oksana Gavrilova,et al.  p53 Regulates Mitochondrial Respiration , 2006, Science.

[140]  R. Shaw,et al.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism , 2011, Nature Cell Biology.

[141]  R. Stevens,et al.  Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. , 2012, European journal of cancer.